ENGOT-EN20/GOG-3083/XPORT-EC-042 a phase 3, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy for patients with P53 wild-type, advanced or recurrent endometrial carcinoma Meeting Abstract
| Authors: | Vergote, I.; Mirza, M. R.; Coleman, R.; Fidalgo, J. P.; Monk, B.; Valabrega, G.; Slomovitz, B.; Van Gorp, T.; Moore, K.; Sehouli, J.; Cibula, D.; Levy, T.; Aravantinos, G.; Li, K.; Kalyanapu, P.; Makker, V. |
| Abstract Title: | ENGOT-EN20/GOG-3083/XPORT-EC-042 a phase 3, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy for patients with P53 wild-type, advanced or recurrent endometrial carcinoma |
| Meeting Title: | IGCS 2023 Annual Meeting |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 33 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2023 Nov 5-7 |
| Meeting Location: | Seoul, South Korea |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2023-11-01 |
| Start Page: | A251 |
| Language: | English |
| ACCESSION: | WOS:001262421600307 |
| DOI: | 10.1136/ijgc-2023-IGCS.472 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TP010/#397 -- Source: Wos |
